Skip to main content
. 2020 Dec 12;16(7):1229–1234. doi: 10.4103/1673-5374.301018

Figure 5.

Figure 5

The effect of tPCS on the immunopositivities of MAP-2, GAP-43, and GFAP around the ischemic penumbra of cerebral infarction rats.

(A) The immunopositivities of MAP-2, GAP-43, and GFAP around the cerebral infarction in rats. Scale bar: 50 μm. Red arrows indicate a positive expression (green); a indicates the infarction area; b indicates the ischemic penumbra. (B–D) Quantitative results of MAP-2-, GAP-43-, and GFAP-positive cells in a 200× magnification area. The data are expressed as the mean ± SD (n = 8). *P < 0.05, **P < 0.01 (one-way analysis of variance followed by the least significant difference test). GAP-43: Growth-associated protein-43; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GFAP: glial fibrillary acidic protein; MAP-2: microtubule-associated protein-2; MCAO: middle cerebral artery occlusion; tPCS: transcranial pulse current stimulation.